The FDA is allowing Sarepta to resume shipments of Elevidys (delandistrogene moxeparvovec) to ambulatory patients with Duchenne muscular dystrophy.

The US Food and Drug Administration’s (FDA) top vaccine official is stepping down after just three months in a role that upset drug companies, patient groups and some political leaders.